Alexandre Hideo‐Kajita

In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris — DREAMS 2G) in de novo coronary lesions: Insights from the BIOSOLVE-II First-In-Man Trial

Héctor M. García‐García, Michael Haude, Kayode O. Kuku et al. · International Journal of Cardiology · 2017 · 72 citations

Biosolve-ii First-in-man Trial, Engineering, Health Sciences +11

Standards for quantitative assessments by coronary computed tomography angiography (CCTA)

Koen Nieman, Héctor M. García‐García, Alexandre Hideo‐Kajita et al. · Journal of cardiovascular computed tomography · 2024 · 61 citations · Full text

Vascular Image, Cardiovascular Disease, Medical Imaging +11

Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12 months: Pooled patient level analysis from BIOSOLVE II–III and BIOFLOW II trials

Alexandre Hideo‐Kajita, Héctor M. García‐García, Paul Kolm et al. · International Journal of Cardiology · 2019 · 31 citations · Full text

Urology, Endovascular Technique, Cardiovascular Disease +9

Coronary fractional flow reserve derived from intravascular ultrasound imaging: Validation of a new computational method of fusion between anatomy and physiology

Cristiano Guedes Bezerra, Alexandre Hideo‐Kajita, Carlos A. Bulant et al. · Catheterization and Cardiovascular Interventions · 2018 · 30 citations

The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study

Mateus Paiva Marques Feitosa, Eduardo Gomes Lima, Alexandre Abizaid et al. · Diabetology & Metabolic Syndrome · 2023 · 21 citations · Full text